Clinical Trial Update: First Line Hepato Cellular Carcinoma (HCC) [Phase 3]

View source ↗

Summary

A Phase 3 trial for first-line hepatocellular carcinoma has completed. The study is sponsored by Bristol-Myers Squibb.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Hepato Cellular Carcinoma (HCC) | Phase 3 | Status: COMPLETED